Total Funding
61
71
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
75023
Eutropics Pharmaceuticals is advancing personalized medicine provider in guiding patient cancer treatments.
- Michael Cardone: Co-Founder, President and CEO
About the Company
Eutropics Pharmaceuticals is a team of skilled scientists and project managers that drive LDT and IVD testing from inception through clinical trials. Eutropics investigates apoptosis and immunological signaling networks to find functional biomarkers. The capacity of Eutropics to build unique biomarker assays that profile peripheral blood or bone
marrow biopsies has been shown to be useful in AML, CLL, MM, ALL, DLBCL, MDS, and other heme-malignancies.
